Laboratory of Vascular Biology, Institute of Molecular Medicine, Peking University, Beijing 100871, China.
Cell Res. 2013 Jun;23(6):820-34. doi: 10.1038/cr.2013.56. Epub 2013 Apr 23.
Regulated endothelial exocytosis of Weibel-Palade bodies (WPBs), the first stage in leukocyte trafficking, plays a pivotal role in inflammation and injury. Acute mechanical stretch has been closely associated with vascular inflammation, although the precise mechanism is unknown. Here, we show that hypertensive stretch regulates the exocytosis of WPBs of endothelial cells (ECs) through VEGF receptor 2 (VEGFR2) signaling pathways. Stretch triggers a rapid release (within minutes) of von Willebrand factor and interleukin-8 from WPBs in cultured human ECs, promoting the interaction between leukocytes and ECs through the translocation of P-selectin to the cell membrane. We further show that hypertensive stretch significantly induces P-selectin translocation of intact ECs and enhances leukocyte adhesion both ex vivo and in vivo. Stretch-induced endothelial exocytosis is mediated via a VEGFR2/PLCγ1/calcium pathway. Interestingly, stretch also induces a negative feedback via a VEGFR2/Akt/nitric oxide pathway. Such dual effects are confirmed using pharmacological and genetic approaches in carotid artery segments, as well as in acute hypertensive mouse models. These studies reveal mechanical stretch as a potent agonist for endothelial exocytosis, which is modulated by VEGFR2 signaling. Thus, VEGFR2 signaling pathways may represent novel therapeutic targets in limiting hypertensive stretch-related inflammation.
血管内皮细胞(ECs)中 Weibel-Palade 体(WPB)的受调控胞吐作用是白细胞迁移的第一阶段,在炎症和损伤中起着关键作用。急性机械拉伸与血管炎症密切相关,但确切机制尚不清楚。在这里,我们表明高血压拉伸通过血管内皮生长因子受体 2(VEGFR2)信号通路调节 ECs 中 WPB 的胞吐作用。拉伸触发 WPB 中 von Willebrand 因子和白细胞介素-8 的快速释放(在几分钟内),通过 P-选择素向细胞膜的易位促进白细胞与 ECs 的相互作用。我们进一步表明,高血压拉伸显著诱导完整 ECs 中 P-选择素的易位,并增强白细胞黏附作用,无论是在体外用还是在体内。拉伸诱导的内皮细胞胞吐作用是通过 VEGFR2/PLCγ1/钙途径介导的。有趣的是,拉伸还通过 VEGFR2/Akt/一氧化氮途径诱导负反馈。在颈动脉段以及急性高血压小鼠模型中,通过药理学和遗传学方法证实了这种双重作用。这些研究揭示了机械拉伸作为内皮细胞胞吐作用的一种有效激动剂,受 VEGFR2 信号的调节。因此,VEGFR2 信号通路可能代表限制高血压相关炎症的新型治疗靶点。